CLDN1 and colorectal carcinoma: None of the top-20 ranked upregulated biomarkers in CRC had prognostic value, except the previously identified biomarkers ESM1 and CLDN1. However, moving down in the importance-ranking list we identified seven new biomarkers with sex-specific prognostic values (Figure 6 and Table 2).